EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Proteomics Approaches for Discovering Novel Protein Biomarkers in Inflammatory Bowel Disease-Related Cancer

Tommaso Saccon iD, Matilde Bergamo, Cinzia Franchin iD

Biomolecules · 17.09.2025 · 15 (9) · 1328

DOI: 10.3390/biom15091328 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 17.09.2025. Verfasst von Tommaso Saccon und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Via F. Marzolo 5, 35131 Padova, Italy. Hauptthemen laut MEDLINE: Proteomics, Inflammatory Bowel Diseases, Biomarkers, Tumor, Colorectal Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 89 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Padua, Budget Integrato per la Ricerca dei Dipartimenti (BIRD).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel disease (IBD) is an autoimmune condition with an increasing incidence worldwide, which manifests in two pathological forms: Crohn’s disease (CD) or ulcerative colitis (UC). Both cause chronic inflammation of the digestive tract, although they can present different locations and with different symptoms. To date, the pathogenesis of IBD remains unclear. One of the major complications of these diseases is colorectal cancer. Several studies have reported a correlation between chronic intestinal inflammation and an increased risk of malignancy. Persistent inflammation damages the intestinal mucosa and epithelial wall, altering gut permeability and the local microenvironment. Moreover, the heightened activity of the immune system leads to an increased production of reactive oxygen and nitrogen species (ROS and RNS), increasing the risk of DNA mutation and cell transformation. In addition, some current therapies used to treat IBD and induce remission may contribute to carcinogenesis or impair immune surveillance due to their immunosuppressive activity. The management of cancer risk for IBD patients remains a challenge, and existing screening methods are often invasive (endoscopies, biopsies), resulting in low patient compliance. To address this unmet clinical need, researchers have started using proteomics to identify novel biomarkers that could predict cancer risk in IBD patients in a non-invasive manner. This review aims to examine the current state of knowledge regarding the correlation between IBD and cancer, with a special focus on the biomarkers discovered through proteomic approaches, and their potential application in routine clinical screening. In our view, proteomics represents a powerful and rapidly evolving strategy for biomarker discovery, with the potential to complement or even replace invasive procedures. Its future clinical impact will rely on translating current research advances into robust and accessible diagnostic tools.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProteomicsInflammatory Bowel DiseasesBiomarkers, TumorColorectal NeoplasmsHumansBiomarkersAnimals

Stichwörter der Autor:innen

IBDIBD therapiesIBD-related cancergut inflammationproteomics

Substanzen

Biomarkers, TumorBiomarkers

Autor:innen und Institutionen

  • Department of Pharmaceutical and Pharmacological Sciences, University of Padova, Via F. Marzolo 5, 35131 Padova, Italy.
  • Department of Pharmaceutical and Pharmacological Sciences, Mass Spectrometry Facility (MS@DSF), University of Padova, Via F. Marzolo 5, 35131 Padova, Italy.

ORCID-Profile: Tommaso Saccon, Cinzia Franchin

Förderung

  • University of Padua
  • Budget Integrato per la Ricerca dei Dipartimenti (BIRD)

Zitieren

APA

Saccon, T., Bergamo, M., & Franchin, C. (2025). Proteomics Approaches for Discovering Novel Protein Biomarkers in Inflammatory Bowel Disease-Related Cancer. Biomolecules, 15(9), 1328. https://doi.org/10.3390/biom15091328

Vancouver

Saccon T, Bergamo M, Franchin C. Proteomics Approaches for Discovering Novel Protein Biomarkers in Inflammatory Bowel Disease-Related Cancer. Biomolecules. 2025;15(9):1328. doi:10.3390/biom15091328

BibTeX
@article{Saccon2025,
  author = {Saccon, Tommaso and Bergamo, Matilde and Franchin, Cinzia},
  title = {Proteomics Approaches for Discovering Novel Protein Biomarkers in Inflammatory Bowel Disease-Related Cancer},
  journal = {Biomolecules},
  year = {2025},
  volume = {15},
  number = {9},
  pages = {1328},
  doi = {10.3390/biom15091328}
}
Kostenlos starten →